Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

957
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
957
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

214
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
214
Cancer Survival Analysis01:21

Cancer Survival Analysis

445
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
445
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

127
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
127
Prevalence and Incidence01:08

Prevalence and Incidence

783
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
783
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

147
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
147

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Exploring pathways between residential greenness and antepartum stillbirth: A mediation analysis.

Environmental epidemiology (Philadelphia, Pa.)·2026
Same author

Global seroprevalence of hepatitis E among people living with HIV: a systematic review and meta-analysis.

Epidemiologic reviews·2026
Same author

Prevalence of hepatitis B in Latin America and the Caribbean: a systematic review and meta-analysis.

Archives of virology·2026
Same author

Factors associated with stillbirth in São Paulo, Brazil: FetRiskS - a multidisciplinary case-control study.

BMC pregnancy and childbirth·2025
Same author

Prevalence of vaccine-induced immunity to hepatitis B in cancer patients: A 13-year analysis in a quaternary oncological center.

Cancer epidemiology·2025
Same author

Aspartate Aminotransferase to Platelet Ratio Index (APRI), Göteborg University Cirrhosis Index (GUCI), and Fibrosis 4 Score (FIB-4) proved to be the optimal biomarkers for the assessment of liver fibrosis in patients chronically infected with hepatitis C virus in Brazil.

Revista da Associacao Medica Brasileira (1992)·2025

Video Experimental Relacionado

Updated: Sep 8, 2025

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.7K

Mortalidad por hepatitis C crónica en Brasil desde 2000 hasta 2019: un análisis de múltiples causas de muerte

Larissa Festa1, Gerusa Maria Figueiredo1, Fatima Mitiko Tengan1

  • 1Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil.

Clinics (Sao Paulo, Brazil)
|September 6, 2025
PubMed
Resumen
Este resumen es generado por máquina.

La mortalidad por hepatitis C crónica (CHC) en Brasil está subestimada. Muchas muertes enumeran la CHC como una causa asociada, no la causa subyacente, destacando problemas en la codificación del certificado de defunción.

Palabras clave:
Hepatitis C. La mortalidad. Las causas de la muerte. El Brasil

Más Videos Relacionados

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.4K
A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.3K

Videos de Experimentos Relacionados

Last Updated: Sep 8, 2025

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.7K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.4K
A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.3K

Área de la Ciencia:

  • Hepatología
  • Salud pública
  • Epidemiología

Sus antecedentes:

  • Las estadísticas convencionales de mortalidad pueden subestimar el impacto total de la hepatitis C crónica (CHC).
  • Los datos precisos de mortalidad son cruciales para comprender la carga de la enfermedad e informar las estrategias de salud pública.

Objetivo del estudio:

  • Analizar las muertes atribuidas a la CHC en Brasil entre 2000 y 2019.
  • Evaluar la CHC como una causa subyacente y múltiple de muerte.
  • Para cuantificar la subestimación de la mortalidad por CHC.

Principales métodos:

  • Estudio ecológico que utiliza datos del Sistema de Información de Mortalidad de Brasil (2000-2019).
  • Análisis descriptivo de las causas de muerte y de las variables sociodemográficas.
  • Comparación de la CHC como causa subyacente frente a una causa asociada de muerte.

Principales resultados:

  • 33,115 muertes mencionaron CHC; 25,390 (76.67%) lo mencionaron como la causa subyacente.
  • La mortalidad por CHC fue inferior en un 30.42%, con 7.725 muertes que la enumeran como una causa asociada (a menudo con cáncer de hígado).
  • Las muertes relacionadas con CHC afectaron predominantemente a hombres, individuos blancos, de más de 60 años de edad, con más de 12 años de educación.

Conclusiones:

  • Se observó una subenumeración significativa de la mortalidad por CHC en Brasil entre 2000 y 2019.
  • Las prácticas inadecuadas de clasificación y codificación de los certificados de defunción contribuyen al recuento insuficiente.
  • Se recomienda mejorar el cumplimiento del certificado de defunción y la codificación de la causa de muerte para obtener indicadores precisos de mortalidad por hepatitis C.